Microdermis Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Microdermis General Information

Description

Developer of dermatological products designed to pave the way for development of persistent germ free healthy skin. The company's products offer a broad spectrum of skin care treatments that include hand sanitization and wound care designed to bolster skin health, enabling users to benefit from a healthy skin by providing the skin cells at the stratum granulosum layer with a plethora of nutrients to enhance skin health.

Contact Information

Website
www.microdermis.com
Formerly Known As
DRSS Global, LLC
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 103 Carnegie Center
  • Suite 300
  • Princeton, NJ 08540
  • United States
+1 (609)
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Drug Delivery
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 103 Carnegie Center
  • Suite 300
  • Princeton, NJ 08540
  • United States
+1 (609)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microdermis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 01-Feb-2019 Completed Out of Business
7. Later Stage VC 29-Dec-2015 Completed Generating Revenue
6. Later Stage VC 25-Nov-2014 Completed Generating Revenue
5. Early Stage VC (Series A2) 04-Sep-2012 Completed Startup
4. Early Stage VC 12-May-2011 Completed Startup
3. Early Stage VC (Series A) 25-Oct-2010 Completed Startup
2. Early Stage VC 13-Apr-2010 $1.01M $1.01M Completed Startup
1. Seed Round Completed Startup
To view Microdermis’s complete valuation and funding history, request access »

Microdermis Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
Series A 80,750,000 $0.001000 $0.12 $0.12 1x $0.12 47.92%
To view Microdermis’s complete cap table history, request access »

Microdermis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of dermatological products designed to pave the way for development of persistent germ free healthy skin. The
Pharmaceuticals
Princeton, NJ

Pune, India
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microdermis Competitors (11)

One of Microdermis’s 11 competitors is Brinton Pharmaceuticals, a Private Equity-Backed company based in Pune, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Brinton Pharmaceuticals Private Equity-Backed Pune, India
NVN Liquidation Formerly VC-backed Durham, NC
Clinuvel Pharmaceuticals Corporation Melbourne, Australia
Dermata Formerly VC-backed San Diego, CA
Aprecia (Drug Delivery) Venture Capital-Backed Blue Ash, OH
You’re viewing 5 of 11 competitors. Get the full list »

Microdermis Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • Pending

  • Expiring in next 12 mo

Microdermis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20130121953-A1 Compositions Inactive 31-Oct-2011
US-20180243424-A1 Compositions Inactive 31-Oct-2011
EP-2773201-A1 Improved compositions Active 31-Oct-2011
EP-2773201-B1 Improved compositions comprising povidone-iodine complex Inactive 31-Oct-2011
EP-2773201-A4 Improved compositions Active 31-Oct-2011 A61K47/44
To view Microdermis’s complete patent history, request access »

Ready to get started?

Request a free trial

Microdermis FAQs

  • When was Microdermis founded?

    Microdermis was founded in 2008.

  • Where is Microdermis headquartered?

    Microdermis is headquartered in Princeton, NJ.

  • What industry is Microdermis in?

    Microdermis’s primary industry is Pharmaceuticals.

  • Is Microdermis a private or public company?

    Microdermis is a Private company.

  • What is Microdermis’s current revenue?

    The current revenue for Microdermis is .

  • How much funding has Microdermis raised over time?

    Microdermis has raised $7.09M.

  • Who are Microdermis’s competitors?

    Brinton Pharmaceuticals, NVN Liquidation, Clinuvel Pharmaceuticals, Dermata, and Aprecia (Drug Delivery) are some of the 11 competitors of Microdermis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »